Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02923401 · ClinicalTrials.gov registry record · NA

High-Intensity Interval Training for Women at Heightened Risk for Breast Cancer

A NA study, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
39
Enrollment target

NCT02923401: Completed NA study, sponsored by M.D. Anderson Cancer Center.

NCT02923401 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02923401, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target

Study Summary

The goal of this research study is to learn if there is a level of exercise training that is more effective in lowering biomarker levels that are linked to breast cancer risk. Biomarkers are found in the blood/tissue and may be related to your reaction to exercise. This is an investigational study. Up to 72 participants will be enrolled in this study. All will take part at MD Anderson.

Interventions

  • OTHER Exercise
  • BEHAVIORAL Questionnaires
  • BEHAVIORAL Phone Call
  • BEHAVIORAL Motivational Session
  • OTHER Printed Materials

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2016-09-30
Est. Completion 2022-01-05
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT02923401

The ClinicalTrials.gov registry entry for NCT02923401 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Exercise is the first listed.

NCT02923401 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02923401 about?

NCT02923401 is a clinical study titled "High-Intensity Interval Training for Women at Heightened Risk for Breast Cancer". The goal of this research study is to learn if there is a level of exercise training that is more effective in lowering biomarker levels that are linked to breast cancer risk. Biomarkers are found in the blood/tissue and may be related to your reaction to exercise. This is an investigational study....

What is the current status of trial NCT02923401?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2016-09-30. Estimated completion is 2022-01-05.

What interventions are being tested in trial NCT02923401?

The interventions under investigation include: Exercise (OTHER), Questionnaires (BEHAVIORAL), Phone Call (BEHAVIORAL), Motivational Session (BEHAVIORAL), Printed Materials (OTHER).

Who is sponsoring clinical trial NCT02923401?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.